VYGR- Voyager Therapeutics, Inc.

Name: Voyager Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Voyager Therapeutics, Inc. (VYGR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Sandrock Alfred	484.1K	$1.96M	-
COO	Swartz Robin	199.7K	$808.9K	-
Other	Ferguson Toby	183.9K	$744.9K	-
CFO	Jorgensen Nathan D.	151.4K	$613.2K	-
Other	Carter Todd Alfred	145.7K	$590.2K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 24, 2026	Carter Todd Alfred69	Chief Scientific Officer	Sell	4,174	$3.76	$15,694.24	-2.8%	-	-
Feb 24, 2026	Sandrock Alfred67	President And CEO	Sell	14,197	$3.79	$53,806.63	-2.8%	-	-
Feb 24, 2026	Swartz Robin69	COO &Cbo	Sell	6,458	$3.77	$24,346.66	-3.1%	-	-
Feb 24, 2026	Jorgensen Nathan D.	Chief Financial Officer	Sell	4,668	$3.77	$17,598.36	-3.0%	-	-
Feb 10, 2026	Sandrock Alfred67	President And CEO	Sell	12,192	$3.78	$46,085.76	-2.3%	-	-
Feb 10, 2026	Swartz Robin69	COO &Cbo	Sell	4,569	$3.85	$17,590.65	-2.1%	-	-
Feb 10, 2026	Carter Todd Alfred69	Chief Scientific Officer	Sell	3,525	$3.85	$13,571.25	-2.2%	-	-
Oct 3, 2025	Jorgensen Nathan D.	Chief Financial Officer	Sell	7,666	$4.78	$36,643.48	-5.8%	-17.1%	-
Aug 18, 2025	Ferguson Toby	Chief Medical Officer	Sell	19,000	$3.73	$70,870.00	-12.0%	+7.0%	-
Apr 2, 2025	Ferguson Toby	Chief Medical Officer	Sell	10,086	$3.43	$34,594.98	-6.0%	-8.5%	+16.1%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC